首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >The effect of selective 5-hydroxytryptamine uptake inhibitors on 5-methoxy-NN-dimethyltryptamine-induced ejaculation in the rat.
【2h】

The effect of selective 5-hydroxytryptamine uptake inhibitors on 5-methoxy-NN-dimethyltryptamine-induced ejaculation in the rat.

机译:选择性5-羟色胺摄取抑制剂对大鼠5-甲氧基-NN-二甲基色胺诱导的射精的影响。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The ejaculatory response and the 5-hydroxytryptamine (5-HT) behavioural syndrome induced by 5-methoxy-N,N-dimethyltryptamine (5-MeODMT) (3 mg kg-1 i.p.) were studied following acute and repeated treatment of rats with the selective uptake inhibitors of 5-HT, fluoxetine, zimeldine, alaproclate, and citalopram. The oral doses used were based on the respective ED50 values for uptake inhibition. Acute doses of fluoxetine and zimeldine significantly reduced the ejaculatory response when given 48 h before 5-MeODMT. This blockade was prevented by treatment of the rats with the postsynaptic 5-HT receptor antagonist methergoline. An acute dose of fluoxetine given 7 and 14 days before 5-MeODMT significantly enhanced the ejaculatory response. On day 24, the response returned to the control level. Repeated treatment every second day (5 times over 9 days and 10 times over 19 days) with fluoxetine caused a longer blockade of the ejaculatory response and the sensitization of the response came later than after an acute dose. Parallel with the ejaculatory response three other components of the 5-HT behavioural syndrome also decreased significantly. Acute doses of alaproclate and citalopram significantly blocked the ejaculatory response at 1 h, but they failed to affect the response at any other time point after either acute or repeated treatment. Neither did these drugs attentuate the 5-HT syndrome. It is concluded that acute and repeated treatment of rats with different selective 5-HT uptake inhibitors does not produce a common alteration in 5-HT2-receptor functions.
机译:在反复急性和反复处理大鼠的基础上,研究了由5-甲氧基-N,N-二甲基色胺(5-MeODMT)(3 mg kg-1 ip)诱发的射精反应和5-羟色胺(5-HT)行为综合征。 5-HT,氟西汀,zimeldine,阿拉卡特和西酞普兰的选择性摄取抑制剂。所使用的口服剂量基于相应的ED50抑制吸收值。在5-MeODMT给药前48小时给予氟西汀和zimeldine急性剂量可显着降低射精反应。通过用突触后5-HT受体拮抗剂美索哥林治疗大鼠,可以防止这种阻断作用。在5-MeODMT前7和14天给予氟西汀急性剂量可显着增强射精反应。在第24天,响应返回到控制级别。每隔两天重复用氟西汀治疗(9天5次,19天10次)导致更长的射精反应阻滞,并且敏化反应的发生要晚于急性剂量。与射精反应平行的5-HT行为综合症的其他三个成分也显着降低。急性剂量的aaproclate和西酞普兰在1 h时明显阻断了射精反应,但在急性或反复治疗后的任何其他时间点均未影响该反应。这些药物也不能减轻5-HT综合征。结论是,用不同的选择性5-HT摄取抑制剂对大鼠进行急性和反复治疗不会在5-HT2-受体功能上产生共同的改变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号